Status:
COMPLETED
Contingency Management to Enhance Office-Based Buprenorphine Treatment
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Opioid-use Disorder
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Contingency Management interventions provide incentives to substance abuse patients when patients meet therapeutic goals. This project will compare the effectiveness of two Contingency Management inte...
Detailed Description
Opioid use has increased to epidemic levels in the United States and has been associated with a dramatic increase in overdose deaths. Buprenorphine is a safe, well-tolerated, and evidence-based medica...
Eligibility Criteria
Inclusion
- Opioid use disorder
- Enrolled in buprenorphine treatment
Exclusion
- Unwilling or unable to use a smartphone
Key Trial Info
Start Date :
January 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
375 Patients enrolled
Trial Details
Trial ID
NCT04024059
Start Date
January 31 2020
End Date
July 1 2024
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Learning and Health
Baltimore, Maryland, United States, 21224